The Oral Microbiome and Systemic Disease: From Microbial Dysbiosis to Therapeutic Opportunities
Abstract
The oral microbiome is a complex community of microorganisms that maintain oral homeostasis and continuously engage host immune and metabolic pathways. The disruption of this ecosystem can lead to dysbiosis, a condition that is increasingly linked to systemic diseases relating to the cardiovascular, metabolic, respiratory, gastrointestinal, neurological, and reproductive systems. This review discusses the biological mechanisms linking oral dysbiosis to systemic disease, such as microbial dissemination, disruption of the epithelial barrier, changes in microbial metabolites, immune activation, and oral–gut microbial interactions. It also highlights the difference between epidemiological association and causality, and the role of longitudinal, multi-omics, and interventional studies. Selective antimicrobials, probiotics, postbiotics, bacteriophages, host-directed therapies, and delivery systems such as nanotechnology are considered potential solutions to restore the microbial and inflammatory balance. Further, with an increasing number of studies investigating microbiome profiling and multi-omics, personalized risk assessment and intervention can be achieved. In conclusion, the oral microbiome is a potentially modifiable interface between local microbial ecology and systemic health, but more compelling evidence of causation, standardized assessment of the oral microbiome, and mechanism-based clinical trials will be necessary to develop clinically effective therapies.